Response rates and outcomes in newly-diagnosed multiple myeloma (NDMM) patient subgroups receiving RVd±ASCT plus lenalidomide maintenance until progression in the phase 3 determination trial Meeting Abstract
| Authors: | Hassoun, H.; Jacobus, S. J.; Voorhees, P. M.; Zonder, J. A.; Lonial, S.; Raje, N.; Medvedova, E.; McCarthy, P. L.; Libby, E. N.; Reeves, B.; Orlowski, R. Z.; Anderson, L. D. Jr; Milner, C. P.; Gasparetto, C.; Agha, M. E.; Khan, A. M.; Hurd, D. D.; Avigan, D. E.; Costello, C.; Jakubowiak, A.; Kaufman, J. L.; Yee, A. J.; Scott, E.; Torka, P.; Wang, M.; Nadeem, O.; Laubach, J. P.; Pasquini, M. C.; Giralt, S.; Masone, K.; Samur, M.; Perrot, A.; Moreau, P.; Avet-Loiseau, H.; Weller, E.; Munshi, N. C.; Anderson, K. C.; Richardson, P. |
| Abstract Title: | Response rates and outcomes in newly-diagnosed multiple myeloma (NDMM) patient subgroups receiving RVd±ASCT plus lenalidomide maintenance until progression in the phase 3 determination trial |
| Meeting Title: | 49th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) |
| Journal Title: | Bone Marrow Transplantation |
| Volume: | 58 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Apr 23-26 |
| Meeting Location: | Paris, France |
| ISSN: | 0268-3369 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2023-12-01 |
| Start Page: | 108 |
| End Page: | 110 |
| Language: | English |
| ACCESSION: | WOS:001110902800122 |
| PROVIDER: | wos |
| PUBMED: | 37945720 |
| DOI: | 10.1038/s41409-023-02055-8 |
| Notes: | Meeting Abstract: O121 -- Found in section, "Physicians - Oral Sessions" -- This was a hybrid meeting -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
